38 related articles for article (PubMed ID: 26125673)
1. Papillary Tumors of Pineal Region: A Single-Center Experience in Management of 11 Cases.
Bora S; Santhoor HA; Kumar A; Das S; Sharma MC; Mishra S; Singh PK; Laythalling RK; Kale SS
World Neurosurg; 2024 Apr; 184():e486-e493. PubMed ID: 38307196
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract][Full Text] [Related]
3. Sialadenoma papilliferum-like intraductal papillary tumor with unveiling BRAF V600E and PIK3CA H1047R mutations: Case report with molecular analysis and literature review.
Alsugair Z; Neuhart A; Benzerdjeb N; Champagnac A; Pissaloux D; Baltres A
Int J Surg Case Rep; 2024 May; 118():109611. PubMed ID: 38636162
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature.
Losa M; Mazza E; Pedone E; Nocera G; Liscia N; Reni M; Mortini P
J Endocrinol Invest; 2024 May; ():. PubMed ID: 38696125
[TBL] [Abstract][Full Text] [Related]
5. Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region.
Coy S; Dubuc AM; Dahiya S; Ligon KL; Vasiljevic A; Santagata S
Am J Surg Pathol; 2017 Oct; 41(10):1410-1421. PubMed ID: 28719464
[TBL] [Abstract][Full Text] [Related]
6. Papillary tumor of the pineal region in pediatric patient - A case report.
Nemir J; Maric LS; Trbojevic T; Zarkovic K; Jadrijević-Cvrlje F
Surg Neurol Int; 2022; 13():488. PubMed ID: 36447897
[TBL] [Abstract][Full Text] [Related]
7. Pineal region tumors: pathophysiological mechanisms of presenting symptoms.
Mavridis IN; Pyrgelis ES; Agapiou E; Meliou M
Am J Transl Res; 2021; 13(6):5758-5766. PubMed ID: 34306324
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
[TBL] [Abstract][Full Text] [Related]
9. [BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].
Lopes JP; Fonseca E
Acta Med Port; 2011 Dec; 24 Suppl 4():855-68. PubMed ID: 22863493
[TBL] [Abstract][Full Text] [Related]
10. Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region.
Cimino PJ; Gonzalez-Cuyar LF; Perry A; Dahiya S
Neurosurgery; 2015 Oct; 77(4):621-8. PubMed ID: 26125673
[TBL] [Abstract][Full Text] [Related]
11. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.
Zhu X; Luo Y; Bai Q; Lu Y; Lu Y; Wu L; Zhou X
Exp Mol Pathol; 2016 Feb; 100(1):236-41. PubMed ID: 26795218
[TBL] [Abstract][Full Text] [Related]
12. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma.
Givens DJ; Buchmann LO; Agarwal AM; Grimmer JF; Hunt JP
Laryngoscope; 2014 Sep; 124(9):E389-93. PubMed ID: 24604709
[TBL] [Abstract][Full Text] [Related]
14. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
Ilie MI; Lassalle S; Long-Mira E; Bonnetaud C; Bordone O; Lespinet V; Lamy A; Sabourin JC; Haudebourg J; Butori C; Guevara N; Peyrottes I; Sadoul JL; Bozec A; Santini J; Capper D; von Deimling A; Emile JF; Hofman V; Hofman P
Thyroid; 2014 May; 24(5):858-66. PubMed ID: 24417277
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
